P78L (p.Pro78Leu) variant of NLGN3 (Neuroligin-3)

P78L (p.Pro78Leu) in NLGN3 (Neuroligin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.83 / 1. The record also includes population frequency data and structural context.

P78L (p.Pro78Leu) variant details